08749nam 2203049z- 450 991055711470332120231214133556.0(CKB)5400000000040899(oapen)https://directory.doabooks.org/handle/20.500.12854/69077(EXLCZ)99540000000004089920202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierCancer NanomedicineBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 electronic resource (510 p.)3-03943-058-0 3-03943-059-9 This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.Technology: general issuesbicsscantibody drug conjugate (ADC)PD-L1tumor spheroid disruptionimmune modulationdoxorubicingraphene oxideadsorptioncathepsin Dcathepsin Lanti-metastatic enzyme cancer therapynanoparticlestargeted delivery systemsiRNAosteopontinmammary carcinomamesenchymal stem cells (MSCs)TAT peptidePLGApaclitaxelnano-engineered MSCsorthotopic lung tumor modelintracranial gliomaimmunotherapyCPMVviral nanoparticlesin situ vaccinealbumin nanoparticlesmicrobubbleultrasoundtheranosticshepatocellular carcinomaVX2 tumorintra-arterial chemotherapylung cancernanomedicineclinical statuscancer therapybreast cancercell signalingactive targetingpassive targetingEPR effectoncogenesnanoparticledrug deliveryligandtumor targetingbiodistributionMesoporous silica nanoparticledrug delivery systemtarget treatmentlanthanide metalhyaluronic acidhyaluronidasedrug combinationeverolimusdual-targetingmagnetic nanoparticlesmonoclonal antibodiesnanostructured lipid carrierplatelet membranebiomimicryplasmonic photothermal therapygold nanorodssurgerybleedingdogscatsstimuli-responsiveDOXSN38CSCssingle-walled carbon nanotubeschirality separationNASHdrug-gene deliverynear IR hyperspectral imagingplasmonicscopperVEGFglioblastomadifferentiated neuroblastomapeptidomimeticsreal-time quantitative polymerase chain reaction (qPCR)actincombinatorial therapyanticancer and antibacterial activitytemoporfindrug-in-cyclodextrin-in-liposomehybrid nanoparticlesmulticellular tumor spheroidscyclodextrinsphotodynamic therapy articleyet reasonably common within the subject disciplineantitumor strategybiomimetic core–shell nanoparticlesNK cell-derived exosomesfolate receptoralbumin nanoparticlemicrofluidiccabazitaxelpolydopamine nanoparticlessizecytotoxicityiron affinityFA-DABA-SMAself-assemblyoncogenic proteinsintracellular disruptionfolic receptor alphapancreatic cancerparvifloron Dalbuminerlotinibphotodynamic therapylipid nanoparticlestumor vectorizationverteporfinovarian carcinomatosisspheroidsintegrinRGD peptidecancer diagnosisradiotherapyhyperthermia therapybiomimeticnanocarriermembrane-wrappedcancertargeted deliveryphotothermal therapyimagingcancer nanomedicinetumor microenvironmentnano–bio interactionsclinical translationmagnetic nanowiresmagnetic hyperthermiamagnetic actuationmagnetic drug targetingtitanate nanotubesgold nanoparticlesvectorizationcolloidal stabilitydocetaxelprostate cancermangiferinanti-topoisomerase activityextracellular vesiclesexosomeschemico-physical functionalizationloadingtranslational medicinenanotechnology: bioengineeringanacardic acidmitoxantronetargeted drug deliveryliposomesmelanomaapoptosisascorbic acidangiogenesisepithelial-to-mesenchymal transitionhypoxiaimmunosuppressionmetabolismnanotherapeuticstumour microenvironmentDNA origamiliposomeremote loadingacute toxicityorganoidsmagnetic silica-coated iron oxide nanochainsphotothermal treatmenthyperthermiacollagencellular microenvironmentlymphadenectomymagnetometersentinel lymph node dissectionSPIONsuperparamagnetic iron oxide nanoparticlesVδ2 T cellszoledronic acidpolymeric nanoconstructanti-tumor immunitycolorectal carcinomaβ-cyclodextrin nanospongesBALB-neuT micebrain tumoursgliomablood brain barrierpolymeric nanoparticlesPEGylationdioleoylphosphatidylethanolaminepoly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymerfolateoxidation-sensitive releasecellular interactionin vitro anti-cancer activitytriple negative breast cancerorganotinmesoporous silica nanoparticlesMDA-MB-231theranostic nanomaterialsnanobiotechnologymolecular imagingnanosystemsnanomicellesovarian cancertumour targetingchemotherapeuticsriboflavinvitamin B2nanomedicinessecondary structuremixed micellepH responsivetargeted therapyanti-cancershear stressflowin vitrotherapeuticsdiagnosticsImmunotherapyTechnology: general issuesHoskins Clareedt1280958Hoskins ClareothBOOK9910557114703321Cancer Nanomedicine3017749UNINA